Literature DB >> 30018056

Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies.

Martha Zavridou1, Sofia Mastoraki1, Areti Strati1, Eleni Tzanikou1, Maria Chimonidou1, Evi Lianidou2.   

Abstract

BACKGROUND: Liquid biopsy provides important information for the prognosis and treatment of cancer patients. In this study, we evaluated the effects of preanalytical conditions on gene expression and DNA methylation analyses in liquid biopsies.
METHODS: We tested the stability of circulating tumor cell (CTC) messenger RNA by spiking MCF-7 cells in healthy donor peripheral blood (PB) drawn into 6 collection-tube types with various storage conditions. CTCs were enriched based on epithelial cell adhesion molecule positivity, and RNA was isolated followed by cDNA synthesis. Gene expression was quantified using RT-quantitative PCR for CK19 and B2M. We evaluated the stability of DNA methylation in plasma under different storage conditions by spiking DNA isolated from MCF-7 cells in healthy donor plasma. Two commercially available sodium bisulfite (SB)-conversion kits were compared, in combination with whole genome amplification (WGA), to evaluate the stability of SB-converted DNA. SB-converted DNA samples were analyzed by real-time methylation-specific PCR (MSP) for ACTB, SOX17, and BRMS1. Quality control was assessed using Levey-Jennings graphs.
RESULTS: RNA-based analysis in CTCs is severely impeded by the preservatives used in many PB collection tubes (except for EDTA), as well as by time to analysis. Plasma and SB-converted DNA samples are stable and can be used safely for MSP when kept at -80 °C. Downstream WGA of SB-converted DNA compensated for the limited amount of available sample in liquid biopsies.
CONCLUSIONS: Standardization of preanalytical conditions and implementation of quality control steps is extremely important for reliable liquid biopsy analysis, and a prerequisite for routine applications in the clinic.
© 2018 American Association for Clinical Chemistry.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30018056     DOI: 10.1373/clinchem.2018.292318

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma.

Authors:  Xiao-Bo Wu; Shu-Ling Hou; Qiao-Hua Zhang; Ning Jia; Min Hou; Wen Shui
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

2.  Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer.

Authors:  Athina Markou; E Tzanikou; G Kallergi; E Pantazaka; V Georgoulias; A Kotsakis; E Lianidou
Journal:  Front Cell Dev Biol       Date:  2021-04-22

Review 3.  Current status of ctDNA in precision oncology for hepatocellular carcinoma.

Authors:  Yan Li; Yuanyuan Zheng; Liwei Wu; Jingjing Li; Jie Ji; Qiang Yu; Weiqi Dai; Jiao Feng; Jianye Wu; Chuanyong Guo
Journal:  J Exp Clin Cancer Res       Date:  2021-04-26

Review 4.  Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook.

Authors:  Evi Lianidou
Journal:  Mol Oncol       Date:  2021-05-14       Impact factor: 6.603

5.  Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR.

Authors:  Aliki Ntzifa; Athanasios Kotsakis; Vassilis Georgoulias; Evi Lianidou
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

6.  Genome-wide study of the effect of blood collection tubes on the cell-free DNA methylome.

Authors:  Ruben Van Paemel; Andries De Koker; Christa Caggiano; Annelien Morlion; Pieter Mestdagh; Bram De Wilde; Jo Vandesompele; Katleen De Preter
Journal:  Epigenetics       Date:  2020-10-19       Impact factor: 4.528

7.  Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinoma.

Authors:  Panagiota Economopoulou; Athina Kladi-Skandali; Areti Strati; George Koytsodontis; Efthymios Kirodimos; Evangelos Giotakis; Pavlos Maragoudakis; Eleni Gagari; Eirini Maratou; George Dimitriadis; Ioannis Kotsantis; Elena Vagia; Maria Anastasiou; Maria Gkotzamanidou; George Kavourakis; Evi Lianidou; Amanda Psyrri
Journal:  ESMO Open       Date:  2020-05

Review 8.  Liquid Biopsy Preservation Solutions for Standardized Pre-Analytical Workflows-Venous Whole Blood and Plasma.

Authors:  Daniel Grölz; Siegfried Hauch; Martin Schlumpberger; Kalle Guenther; Thorsten Voss; Markus Sprenger-Haussels; Uwe Oelmüller
Journal:  Curr Pathobiol Rep       Date:  2018-10-18

9.  Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.

Authors:  Svenja Schneegans; Lelia Lück; Katharina Besler; Leonie Bluhm; Julia-Christina Stadler; Janina Staub; Rüdiger Greinert; Beate Volkmer; Mikael Kubista; Christoffer Gebhardt; Alexander Sartori; Darryl Irwin; Elina Serkkola; Taija Af Hällström; Evi Lianidou; Markus Sprenger-Haussels; Melanie Hussong; Peter Mohr; Stefan W Schneider; Jonathan Shaffer; Klaus Pantel; Harriet Wikman
Journal:  Mol Oncol       Date:  2020-04-04       Impact factor: 6.603

10.  PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients.

Authors:  Athina Markou; Eleni Tzanikou; Areti Strati; Martha Zavridou; Sophia Mastoraki; Evangelos Bournakis; Evi Lianidou
Journal:  Cancers (Basel)       Date:  2020-05-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.